| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 733 | 733 | 747 | 729 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 733 | 733 | 747 | 729 | | | Operating Expenses | | Research Development | 7,401 | 10,808 | 10,848 | 11,885 | | Selling General and Administrative | 3,055 | 5,768 | 9,023 | 3,817 | | Non Recurring |
-
|
-
|
-
| 15,742 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,723) | (15,843) | (19,124) | (30,715) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,546 | 563 | (541) | 3,137 | | Earnings Before Interest And Taxes | (8,177) | (15,280) | (19,665) | (27,578) | | Interest Expense |
-
|
-
|
-
| 1,276 | | Income Before Tax | (8,177) | (15,280) | (19,665) | (28,854) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,177) | (15,280) | (19,665) | (28,854) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,177) | (15,280) | (19,665) | (28,854) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,177) | ($15,280) | ($19,665) | ($28,854) |
|
0.51% Nasdaq 
Income Statement
